Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Bromelain and Saccharomyces Boulardii are closely matched across evidence, studies, and safety.
Verdict
Likely helps
7 of 7 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
13 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Bromelain and Saccharomyces Boulardii have evidence — compare verdict strength side-by-side.
500-2000mg (measured in GDU — aim for 2000-3000 GDU)
On empty stomach for systemic effects, With meals for digestive effects
Capsules standardized to GDU (gelatin digesting units)
250-500mg (5-10 billion CFU) daily
With or without food, At least 2 hours away from antifungals
Capsules (lyophilized)
3-7 days
1-2 weeks
3-7 days
During use
1-3 days
1-2 weeks
Exploring the Therapeutic Potential of Bromelain: Applications, Benefits, and Mechanisms
Nutrients (2024) · Systematic review
It has a long history of traditional medicinal use in various cultures, particularly in Central and South America, where pineapple is native.
Bromelain as a natural anti-inflammatory drug: a systematic review
Natural product research (2025) · Systematic review
Among these compounds, bromelain is highlighted, as a cysteine protease isolated from the Ananas comosus (pineapple) stem.
Bromelain and liver health: A comprehensive systematic review of preclinical studies
Clinical nutrition ESPEN (2025) · Systematic review
Our research suggests that bromelain possesses both prophylactic and curative qualities in terms of liver damage, as supported by its ability to decrease enzyme levels, enhance liver structure, reduce oxidative stress markers, and regulate lipid metabolism.
Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
Frontiers in cellular and infection microbiology (2025) · Meta analysis · n=5036
S. boulardii supplementation in traditional eradication therapy significantly improves the H. pylori eradication rate and reduces the total adverse effects and incidence of diarrhea, bloating, constipation, and nausea.
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes
Gut microbes (2024) · Meta analysis · n=2871
This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut.
Based on meta-analysis showing statistically significant but modest pain reduction (mean difference -0.27). Effect size was small and studies showed moderate heterogeneity.
Based on multiple meta-analyses showing 1.1-1.6 day reduction in diarrhea duration. Effect size appears to plateau at standard therapeutic doses. Limited data on doses above 20 billion CFU.
AI-estimated from published studies. Interpret as directional guidance.
Both Bromelain and Saccharomyces Boulardii are closely matched — the best choice depends on your specific health goals.
For reduce inflammation, Saccharomyces Boulardii has a higher relevance score (90 vs 75).
No known interactions between Bromelain and Saccharomyces Boulardii have been documented in our database. However, always consult a healthcare provider before combining supplements.